Tivozanib for RCC: Unpacking Efficacy, Safety, and Dose Optimization – Bradley McGregor, MD – Dana Farber Genitourinary 3 Mins Read By Dr. Bradley McGregor | Published April 02, 2025Renal cell cancer (RCC) treatment continues to evolve, and Tivozanib (TIVO) is…
